(Q54078474)

English

What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10493490

What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10493490

0 references

immunosuppression

1 reference

based on heuristic

inferred from title

liver transplantation

1 reference

based on heuristic

inferred from title

Thomas E. Starzl

6

object named as

T Starzl

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

John Julian Fung

7

object named as

J Fung

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

Muhammad Abu-Elmagd

5

object named as

K Abu-Elmagd

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10493490

author name string

A Jain

1

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10493490

J Reyes

2

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10493490

R Kashyap

3

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10493490

S Rohal

4

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10493490

language of work or name

0 references

publication date

1 September 1999

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10493490

Annals of Surgery

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10493490

230

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10493490

3

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10493490

441-8; discussion 448-9

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10493490

Randomized trial of cyclosporine microemulsion (neoral) versus conventional cyclosporine in liver transplantation: MILTON study. Multicentre International Study in Liver Transplantation of Neoral.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Comparison of tacrolimus with microemulsion cyclosporine as primary immunosuppression in hepatitis C patients after liver transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Cardiac changes at autopsy in adult liver transplant recipients under tacrolimus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Clinical significance of recurrent primary biliary cirrhosis after liver transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Tacrolimus (FK506): the pros and cons of its use as an immunosuppressant in pediatric liver transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

10 years of pediatric liver transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

The current status of hepatic transplantation at the University of Pittsburgh

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Randomized trial in primary liver transplantation under immunosuppression with FK 506 or cyclosporine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Adverse effects of FK 506 overdosage after liver transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Hepatic transplantation at the University of Pittsburgh: new horizons and paradigms after 30 years of experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

The nephrotoxicity of FK506 as compared with cyclosporine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Randomised trialomania? The multicentre liver transplant trials of tacrolimus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Cyclosporine immunosuppression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

FK 506 for liver, kidney, and pancreas transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Cyclosporine toxicity to organs other than the kidney

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Neurologic complications of FK 506

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Changes in renal function after liver transplantation under FK 506

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Adverse effects associated with the use of FK 506

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Correlation of rejection episodes with FK 506 dosage, FK 506 level, and steroids following primary orthotopic liver transplant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Strategy of FK 506 therapy in liver transplant patients: effect of graft function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

In vivo effect of FK506 on human pancreatic islets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

The question of FK 506 nephrotoxicity after liver transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Liver transplantation under cyclosporine: a decade of experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Expressive dysphasia possibly related to FK506 in two liver transplant recipients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Liver, kidney, and thoracic organ transplantation under FK 506.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Assay of FK 506 in plasma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Oral glucose tolerance test in liver recipients treated with FK 506

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Acute hemodynamic effects of FK 506 during and after orthotopic liver transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

The effects of FK 506 on renal function after liver transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Early trials with FK 506 as primary treatment in liver transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420888

29 September 2018

Long-Term Results after Liver Transplantation in Adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/10493490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of renal function in cyclosporine- and FK-506-treated patients after primary orthotopic liver transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10493490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FK506 trough levels in whole blood and plasma in liver transplant recipients. Correlation with clinical events and side effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/10493490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10493490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infectious complications in liver transplant recipients on tacrolimus. Prospective analysis of 88 consecutive liver transplants

1 reference

https://pubmed.ncbi.nlm.nih.gov/10493490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporine A US Multicenter Trial. US Multicenter Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10493490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Corticosteroid withdrawal after liver transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10493490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrence of primary biliary cirrhosis in the liver allograft: the effect of immunosuppression

1 reference

https://pubmed.ncbi.nlm.nih.gov/10493490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular risk factors in long-term follow-up after orthotopic liver transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10493490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/10493490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term immunosuppression without corticosteroids after orthotopic liver transplantation: a positive therapeutic aim

1 reference

https://pubmed.ncbi.nlm.nih.gov/10493490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Steroid withdrawal is safe and beneficial in stable cyclosporine-treated liver transplant patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/10493490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kaposi's sarcoma in liver transplant recipients on FK506

1 reference

https://pubmed.ncbi.nlm.nih.gov/10493490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term comparison of tacrolimus versus cyclosporine in liver transplantation. The US FK Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10493490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-rate hepatitis and low-rate rejection induced late morbidity and mortality in long-term follow-up after liver transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10493490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversal of early acute rejection with increased doses of tacrolimus in liver transplantation: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10493490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter Comparison of First- and Second-Generation IMx Tacrolimus Microparticle Enzyme Immunoassays in Liver and Kidney Transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10493490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum lipid changes in liver transplantation: effect of steroids withdrawn in a prospective randomized trial under cyclosporine A therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10493490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An analysis of cyclosporine efficacy and toxicity after liver transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10493490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serial decrease in glomerular filtration rate in long-term pediatric liver transplantation survivors treated with cyclosporine

1 reference

https://pubmed.ncbi.nlm.nih.gov/10493490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beyond 1 year after liver transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10493490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/10493490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/00000658-199909000-00016

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10493490

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10493490

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54078474&oldid=1740037091"